MD vs PACS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
MD
PACS
Investment Advisor Scores
PACS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MD | PACS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 8.2102 | 17.8891 | MD |
| PEG Ratio | 0.2433 | 1.1922 | MD |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 4.0% | 9.1% | PACS |
| Earnings Growth | 6.5% | 51.6% | PACS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 55.5/100 | 54.8/100 | MD |
| Profit Margin | 9.0% | 4.9% | MD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MD
MarkupPrice above SMA50, rising 50-day trend (6.6% over 20 days), RSI 54
PACS
NeutralMixed signals - no dominant trend phase, RSI 48
Fundamentals Snapshot
| Metric | MD | PACS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.9 | 16.3 |
| Trailing P/E | 12.5 | 25.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.3% | 0.2% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 2.09 | 1.71 |
| Dividend Yield | — | — |